DK1766412T3 - Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner - Google Patents

Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner

Info

Publication number
DK1766412T3
DK1766412T3 DK05751819T DK05751819T DK1766412T3 DK 1766412 T3 DK1766412 T3 DK 1766412T3 DK 05751819 T DK05751819 T DK 05751819T DK 05751819 T DK05751819 T DK 05751819T DK 1766412 T3 DK1766412 T3 DK 1766412T3
Authority
DK
Denmark
Prior art keywords
compositions
methods
serum glycoproteins
quantifying serum
quantifying
Prior art date
Application number
DK05751819T
Other languages
Danish (da)
English (en)
Inventor
Rudolph H Aebersold
Hui Zhang
Original Assignee
Inst Systems Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Systems Biology filed Critical Inst Systems Biology
Application granted granted Critical
Publication of DK1766412T3 publication Critical patent/DK1766412T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
DK05751819T 2004-05-21 2005-05-20 Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner DK1766412T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57359304P 2004-05-21 2004-05-21
PCT/US2005/017842 WO2005114221A2 (fr) 2004-05-21 2005-05-20 Compositions et methodes de quantification de glycoproteines du serum

Publications (1)

Publication Number Publication Date
DK1766412T3 true DK1766412T3 (da) 2009-05-25

Family

ID=35429005

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05751819T DK1766412T3 (da) 2004-05-21 2005-05-20 Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner

Country Status (6)

Country Link
US (2) US20060141528A1 (fr)
EP (4) EP2302393A1 (fr)
AT (1) ATE427499T1 (fr)
DE (1) DE602005013670D1 (fr)
DK (1) DK1766412T3 (fr)
WO (1) WO2005114221A2 (fr)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124265D1 (de) * 2000-05-05 2006-12-14 Purdue Research Foundation Durch affinität ausgewählte unterschriftspeptide zur identifizierung und quantifizierung von proteinen
WO2003027682A2 (fr) * 2001-09-27 2003-04-03 Purdue Research Foundation Materiaux et procedes regulant les effets isotopiques lors du fractionnement d'analytes
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
US7384754B2 (en) * 2003-10-31 2008-06-10 Agilent Technologies, Inc. Enrichment and tagging of glycosylated proteins
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
US20070099251A1 (en) * 2005-10-17 2007-05-03 Institute For Systems Biology Tissue-and serum-derived glycoproteins and methods of their use
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
WO2008021290A2 (fr) 2006-08-09 2008-02-21 Homestead Clinical Corporation Protéines spécifiques d'organes et procédés d'utilisation
US7879799B2 (en) * 2006-08-10 2011-02-01 Institute For Systems Biology Methods for characterizing glycoproteins and generating antibodies for same
DK2617431T3 (en) 2007-01-10 2017-07-10 Purdue Research Foundation Polypeptide inhibitors of HSP27 kinase and applications therefor
WO2008134526A2 (fr) * 2007-04-27 2008-11-06 University Of Florida Research Foundation Inc. Profilage de glycoprotéines du cancer de la vessie
US8603734B2 (en) * 2007-06-04 2013-12-10 The Johns Hopkins University Biomarkers for prostate cancer
US8835381B2 (en) 2007-06-12 2014-09-16 Glaxosmithkline Llc Methods for detecting protein in plasma
US20100168382A1 (en) * 2007-06-12 2010-07-01 Vladimir Berezin Neuroplastin derived peptides
WO2009006568A1 (fr) * 2007-07-03 2009-01-08 Northeastern University Biomarqueurs pour le diabète, l'obésité, et/ou l'hypertension
WO2009014450A1 (fr) * 2007-07-24 2009-01-29 Sanare As Nouveaux peptides
WO2009021137A2 (fr) 2007-08-07 2009-02-12 Purdue Research Foundation Inhibiteurs de kinase et leurs utilisations
WO2009095925A2 (fr) * 2008-01-31 2009-08-06 Compugen Ltd. Polypeptides et polynucléotides et leurs utilisations en tant que cible médicamenteuse pour produire des médicaments et des produits biologiques
US9327008B2 (en) 2008-12-10 2016-05-03 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
WO2010129187A1 (fr) * 2009-05-08 2010-11-11 Thermo Finnigan Llc Procédés et systèmes de mise en correspondre de productions et d'ions de précurseur
JP6028960B2 (ja) * 2009-07-14 2016-11-24 国立研究開発法人産業技術総合研究所 肝疾患病態指標糖鎖マーカー
WO2011017132A2 (fr) 2009-07-27 2011-02-10 Purdue Research, Foundation Compositions d'inhibiteurs de mk2 et procédés d'amélioration de l'excroissance des neurites, de la neuroprotection et de la régénération des nerfs
US10497466B2 (en) 2010-05-14 2019-12-03 Dh Technologies Development Pte. Ltd. Systems and methods for calculating protein confidence values
SG10201600656WA (en) * 2010-10-27 2016-02-26 Baxter Int FVIII Peptides For Immune Tolerance Induction And Immunodiagnostics
US9403889B2 (en) 2010-11-29 2016-08-02 Integrated Diagnostics, Inc. Diagnostic lung cancer panel and methods for its use
US8772043B2 (en) 2010-12-23 2014-07-08 Pioneer Hi Bred International Inc Universal peptide tags for transgene polypeptide analysis by mass spectrometry
CA2835806A1 (fr) * 2011-05-13 2012-11-22 King's College London Procedes et compositions lies a la sensibilite plaquettaire
AU2012261953A1 (en) 2011-06-03 2013-12-12 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
US9506167B2 (en) 2011-07-29 2016-11-29 Ginkgo Bioworks, Inc. Methods and systems for cell state quantification
US10226238B2 (en) 2011-09-12 2019-03-12 Creatics Llc Non-invasive methods of detecting target molecules
CN103134874B (zh) * 2011-12-01 2015-05-20 成都康弘生物科技有限公司 一种测定蛋白中糖基的方法
US9201044B2 (en) 2011-12-21 2015-12-01 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US9304137B2 (en) 2011-12-21 2016-04-05 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US11913957B2 (en) 2011-12-21 2024-02-27 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
EP3381461B1 (fr) 2012-01-09 2021-03-10 Serpin Pharma, LLC Peptides et leurs procédés d'utilisation
US9452218B2 (en) 2012-03-09 2016-09-27 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
WO2013167153A1 (fr) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Anticorps utiles dans le diagnostic du cancer
JP6296615B2 (ja) * 2012-11-06 2018-03-20 国立大学法人 宮崎大学 新規ペプチドおよびその用途
WO2014100717A2 (fr) 2012-12-21 2014-06-26 Integrated Diagnostics, Inc. Compositions, procédés et kits pour le diagnostic d'un cancer du poumon
AU2014243704A1 (en) 2013-03-13 2015-09-10 Creatics Llc Methods and compositions for detecting pancreatic cancer
GB201310150D0 (en) * 2013-06-07 2013-07-24 Electrophoretics Ltd Methods and compositions relating to alzheimer's disease
WO2015013654A1 (fr) 2013-07-26 2015-01-29 Integrated Diagnostics, Inc. Compositions, méthodes et kits pour le diagnostic du cancer du poumon
WO2015117133A1 (fr) 2014-02-03 2015-08-06 Integrated Diagnostics, Inc. Procédé de quantification intégré pour la mesure de protéines en protéomique clinique
GB201411037D0 (en) * 2014-06-20 2014-08-06 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)
US10000533B2 (en) 2014-06-20 2018-06-19 Immatics Biotechnologies Gmbh Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
WO2016038608A1 (fr) * 2014-09-08 2016-03-17 Carmel Haifa University Economic Corporation Ltd. Peptides dérivés du récepteur de l'angiotensine et leur utilisation
WO2016054114A1 (fr) * 2014-09-29 2016-04-07 The Regents Of The University Of California Composition pour l'expansion de lymphocytes t régulateurs (treg), et le traitement de maladies et affections auto-immunes et inflammatoires
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
DK3273986T3 (da) 2015-03-27 2024-02-12 Immatics Biotechnologies Gmbh Hidtil ukendte peptider og kombination af peptider til anvendelse ved immunterapi mod forskellige tumorer
JP6929272B2 (ja) 2015-08-28 2021-09-01 セルピン ファーマ リミテッド ライアビリティ カンパニー 疾患処置のための方法
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520559D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
CN110114680A (zh) 2016-05-05 2019-08-09 佰欧迪塞克斯公司 用于诊断肺癌的组合物、方法和试剂盒
US9960027B2 (en) 2016-05-25 2018-05-01 Thermo Finnigan Llc Analyzing a complex sample by MS/MS using isotopically-labeled standards
CN111148844A (zh) * 2017-09-01 2020-05-12 韦恩生物科技股份公司 鉴定和使用糖肽作为诊断和治疗监测的生物标记物
ES2710321A1 (es) * 2017-10-20 2019-04-24 Consejo Superior Investigacion Adn polimerasas independientes de cebador y su uso para la sintesis de adn
WO2020223646A1 (fr) 2019-05-02 2020-11-05 Creatics Llc Méthodes de détection du cancer par évaluation de alpha-1-antitrypsine (aat) et elastase de type chymotrypsine dans des échantillons de fluide de lavage gastro-intestinal
CN110563844A (zh) * 2019-09-04 2019-12-13 华中农业大学 一种抗犬白介素31受体的多克隆抗体及其应用
US20220348620A1 (en) * 2019-09-09 2022-11-03 The Wistar Institute Of Anatomy And Biology Engineered Peptide and Peptide Mimetic Compositions and Methods
CN117580584A (zh) * 2021-04-29 2024-02-20 禧尔公司 用于富集特定蛋白质子集的肽修饰纳米颗粒
CN113480629B (zh) * 2021-06-16 2022-08-19 复旦大学 区分肝癌和正常人的末端唾液酸化异构糖肽标志物及其筛查方法
US11542340B1 (en) 2021-10-29 2023-01-03 Biodesix, Inc. Antibodies targeting pulmonary nodule specific biomarkers and uses thereof
NL2030990B1 (en) * 2022-02-17 2023-09-01 Academisch Ziekenhuis Leiden T cell receptors directed against jchain and uses thereof
CN117969642A (zh) * 2024-04-02 2024-05-03 浙江大学 一种植物n-糖链的精准相对定量分析方法及应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2226032B (en) * 1988-12-16 1993-08-18 Urs Heimgartner Detection of glycoproteins
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5079336A (en) * 1989-06-23 1992-01-07 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5264563A (en) 1990-08-24 1993-11-23 Ixsys Inc. Process for synthesizing oligonucleotides with random codons
GB9112504D0 (en) * 1991-06-11 1991-07-31 Merck Sharp & Dohme Cell line
US5986076A (en) 1994-05-11 1999-11-16 Trustees Of Boston University Photocleavable agents and conjugates for the detection and isolation of biomolecules
JPH10507160A (ja) 1994-06-23 1998-07-14 アフィマックス テクノロジーズ エヌ．ブイ． 光活性化合物およびその使用方法
WO1997046589A2 (fr) * 1996-06-07 1997-12-11 Neorx Corporation Anticorps humanises se liant au meme antigene que celui lie par l'anticorps nr-lu-13 et leur utilisation dans des procedes de preciblage
EP0959893A4 (fr) * 1996-12-10 2004-11-10 Sloan Kettering Institutefor C Procede et compositions destines a stimuler une reponse immune a l'egard d'un antigene de differenciation stimule par un antigene modifie
US6046013A (en) * 1997-08-01 2000-04-04 Gti Process for identifying specific antibodies associated with HLA
DE69912444T3 (de) 1998-08-25 2010-05-06 University Of Washington, Seattle Schnelle quantitative analyse von proteinen oder proteinfunktionen in komplexen gemischen
US6407210B1 (en) * 1998-11-09 2002-06-18 University Of Utah Research Foundation Nematode neuromuscular junction GABA receptors and methods related thereto
JP2003518364A (ja) * 1999-05-28 2003-06-10 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ 乳癌、胃癌および前立腺癌関連抗原ならびにそれらの使用
DE60142650D1 (de) 2000-12-26 2010-09-02 Inst Systems Biology Seattle Schnelle und quantitative Proteomanalyse und entsprechende Verfahren
ATE433751T1 (de) * 2001-04-30 2009-07-15 Vertex Pharma Inhibitoren von gsk-3 und kristallstrukturen von gsk-3beta-protein und -proteinkomplexen
WO2003027682A2 (fr) * 2001-09-27 2003-04-03 Purdue Research Foundation Materiaux et procedes regulant les effets isotopiques lors du fractionnement d'analytes
US7183118B2 (en) 2002-06-03 2007-02-27 The Institute For Systems Biology Methods for quantitative proteome analysis of glycoproteins
WO2005007677A2 (fr) * 2003-07-10 2005-01-27 The Institute For Systems Biology Capture par affinite de peptides par micro-agencement et methodes associees
US7593336B2 (en) * 2003-10-31 2009-09-22 Brocade Communications Systems, Inc. Logical ports in trunking
US7348416B2 (en) * 2003-11-21 2008-03-25 Applera Corporation Selective capture and enrichment of proteins expressed on the cell surface

Also Published As

Publication number Publication date
WO2005114221A3 (fr) 2006-12-21
ATE427499T1 (de) 2009-04-15
EP2093569A3 (fr) 2009-11-11
EP1766412A2 (fr) 2007-03-28
EP2302393A8 (fr) 2011-08-03
EP1766412B1 (fr) 2009-04-01
EP2093569A2 (fr) 2009-08-26
EP2302394A1 (fr) 2011-03-30
US20060141528A1 (en) 2006-06-29
WO2005114221A2 (fr) 2005-12-01
DE602005013670D1 (de) 2009-05-14
US20100279382A1 (en) 2010-11-04
EP2302393A1 (fr) 2011-03-30
WO2005114221A8 (fr) 2006-05-04

Similar Documents

Publication Publication Date Title
DK1766412T3 (da) Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner
WO2005111212A3 (fr) Code-barres biologique
WO2005012574A3 (fr) Code a barres biologique
DK1510492T3 (da) Fremgangsmåde til afprövning af et elevatoranlæg og elevatoranlæg
WO2007007192A8 (fr) Utilisation de matrices ioniques pour l'analyse par la spectrometrie de desorption-ionisation par impact laser assistee par matrice
DK1663298T3 (da) Anvendelse af prolinspecifikke endoproteaser til hydrolyse af peptider og proteiner
DK1740197T3 (da) Prolyl-endopeptidease (PEP) og glutamin-endoprotease til behandlingen af cøliaki
DK2270189T3 (da) Glyphosattolerante lucernebegivenheder og fremgangsmåder til detektering deraf
IS6316A (is) Aðferð til erfðafræðilegra greininga
DK1680443T3 (da) Stabiliserede alfa-helix-peptider og anvendelser heraf
DE60309492D1 (de) Arbeitsplatz zur bereitstellung proben
CY1106115T1 (el) Προσδιορισμος κινασης αναπλαστικου λεμφωματος, αντιδραστηρια και συνθεσεις αυτης
DK2327792T3 (da) Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme
EP1700120A4 (fr) Marqueur pour la neuromyelite optique
DE50204020D1 (de) Mikrotom
FI20012271A0 (fi) Menetelmä vastinpisteiden määrittämiseksi
DK1444358T3 (da) Fremgangsmåde til karakterisering og/eller identificering af aktive mekanismer af antimikrobielle teststoffer
ATE363070T1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
DE60213940D1 (de) Proben-Einführungssystem
DE502005009608D1 (de) Vorrichtung zur optischen prüfung von elektronischen bauteilen
DE60219633D1 (de) LÄNGLICHER KANISTER FÜr EINEN AUTOMATISIERTEN MIKROBIOLOGISCHEN ANALYSATOR
MXPA04004018A (es) Metodos de separacion por exclusion para toxicidad de compuestos de prueba.
DE60232728D1 (de) Einrichtung zur erzeugung von gegenseitigen photometrischen effekten
WO2007095378A3 (fr) Marquage de masse pour l'analyse quantitative de biomolécules au moyen de phénylisocyanate étiqueté 13c
EP1468265A4 (fr) Systemes et procedes d'analyse de la phosphorylation de proteines